Free shipping on all orders over $ 500

Ro 0437626

Cat. No. M7201

All AbMole products are for research use only, cannot be used for human consumption.

Ro 0437626 Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Ro 0437626 is a selective P2X1 purinergic receptor antagonist (IC50 = 3 μM) that displays > 30-fold selectivity over P2X2, P2X3 and P2X2/3 receptors (IC50 > 100 μM).

Chemical Information
Molecular Weight 525.66
Formula C27H35N5O4S
CAS Number 134362-79-1
Solubility (25°C) DMSO 52.57 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Drago. Pharmacol Biochem Behav. Dihydroergocristine and memory alterations of aged male rats.

Related P2 Receptor Products
NF449 

NF449 is a highly potent P2X1 receptor antagonist, with IC50s of 0.28, 0.69, and 120 nM for rP2X1, rP2X1+5, P2X2+3, respectively.

NF279 

NF279 is a potent selective and reversible P2X1 receptor antagonist, with an IC50 of 19 nM.

NF110 

NF110 is a P2X3 receptor antagonist (Ki = 36 nM) and inactive toward P2Y receptors stably expressed (IC50s > 10 M).

PSB-12062

PSB-12062 is a potent and selective P2X4 antagonist with an IC50 of 1.38 μM for human P2X4.

NF449 octasodium 

NF449 octasodium is a highly potent P2X1 receptor antagonist, with IC50s of 0.28, 0.69, and 120 nM for rP2X1, rP2X1+5, P2X2+3, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: Ro 0437626 supplier, P2 Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.